Sector valuations Ionis Pharmaceuticals, Inc.
Equities
IONS
US4622221004
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.23 USD | -1.92% |
|
-1.95% | -6.17% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -20.76x | -3711.5x | -0.41x | 13.53x | -20.96x | -19.73x | -.--% | 12.27B | ||
| 28.4x | 3.48x | 1.27x | 5.05x | 15.65x | 22x | 1.16% | 41.67B | ||
| 44.43x | 6.53x | 0.28x | 4.44x | 28.31x | 33.74x | -.--% | 32.6B | ||
| -18.41x | 13.37x | -0.56x | 283.77x | -16.54x | -16.49x | -.--% | 30.97B | ||
| 20.59x | 3.9x | 4.32x | 2.44x | 10.54x | 16.11x | -.--% | 28.23B | ||
| 30.22x | 2.24x | 0.89x | 7.79x | 20x | 24.06x | 0.41% | 26.41B | ||
| 20.54x | 2.16x | 0.7x | 1.83x | 8.04x | 12.72x | 1.3% | 12.12B | ||
| 24.37x | 12.21x | 2.12x | 3.86x | 17.58x | 18.43x | -.--% | 11.86B | ||
| -22.67x | 8.53x | -1.87x | 2214x | -19.17x | -18.35x | -.--% | 9.55B | ||
| -27.78x | 40.42x | 1.06x | 2825.47x | -30.96x | -27.68x | -.--% | 9.11B | ||
| 18.58x | 0.96x | -0.54x | 1.46x | 7.48x | 8.25x | -.--% | 8.89B | ||
| -21.89x | 19.47x | -0.52x | 5.35x | 131.36x | -372.99x | -.--% | 7.89B | ||
| 24.57x | 2.2x | -0.08x | 2.36x | 9.2x | 11.21x | -.--% | 7.27B | ||
| 30.44x | 3.55x | 1.22x | 6.32x | 20.73x | 26.52x | 1.34% | 7.18B | ||
| 37.14x | 3.14x | 0.24x | 5.55x | 15.74x | 17.29x | 0.74% | 6.78B | ||
| -23.04x | 6.01x | 6.99x | 67.7x | -14.35x | -13.92x | -.--% | 6.76B | ||
| 15.73x | 1.86x | 1.95x | 3.41x | 9.39x | 11.65x | -.--% | 6.82B | ||
| 26.62x | - | -0.09x | 12.03x | 20.98x | 22.96x | -.--% | 6.57B | ||
| Average | 10.39x | -210.68x | 0.94x | 303.69x | 11.84x | -13.57x | 0.27% | 15.16B | |
| Weighted average by Cap. | 14.74x | -164.02x | 0.99x | 209.81x | 11.00x | -0.16x | 0.33% |
- Stock Market
- Equities
- IONS Stock
- Sector Ionis Pharmaceuticals, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















